LifeClean International (LCLEAN) Q2 2026 earnings summary

Executive summary

• Revenue declined to 13,418 TSEK in Q2 2026 from 20,285 TSEK year-over-year, reflecting lower sales in both the parent and subsidiary.

• Strategic focus on commercial scaling, international expansion, and operational efficiency, including production consolidation in Vadstena.

• Preparations for US market entry resumed, with strengthened regulatory and commercial groundwork.

• Board proposed delisting from Nasdaq First North Growth Market, pending shareholder approval.

Financial highlights

• Q2 2026 adjusted EBITDA was -5,334 TSEK (vs. -3,359 TSEK), and EBITDA was -4,556 TSEK (vs. -4,181 TSEK) year-over-year.

• Operating income (EBIT) improved to -5,476 TSEK from -6,396 TSEK year-over-year.

• Cash flow from operations was -9,457 TSEK (vs. -7,022 TSEK) in Q2; cash position at period end was 25,638 TSEK.

• For H1 2026, revenue was 28,315 TSEK (vs. 35,073 TSEK), and adjusted EBITDA was -9,914 TSEK (vs. -7,823 TSEK).

• Net result per share for Q2 was -0.005 (vs. -0.026); for H1, -0.011 (vs. -0.060).

Outlook and guidance

• Management sees positive signals in ongoing projects and dialogues, with long sales cycles but improved readiness for growth.

• Continued focus on commercial expansion, international partnerships, and operational streamlining.